Informazione:
Errore:
ID
13685
Descrizione
ODM derived from HSCT forms on http://www.ebmt.org/
collegamento
Keywords
versioni (2)
- 09/02/16 09/02/16 -
- 28/02/16 28/02/16 -
Caricato su
28 febbraio 2016
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Specification of the disease EBMT MDS
Specification of the disease
- StudyEvent: ODM
Similar models
Specification of the disease
- StudyEvent: ODM
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item
Myelodysplastic Syndrome (WHO)-Subclassification (Please use the WHO subclassification if possible)
text
C3463824 (UMLS CUI [1,1])
C0043237 (UMLS CUI [1,2])
C0043237 (UMLS CUI [1,2])
Code List
Myelodysplastic Syndrome (WHO)-Subclassification (Please use the WHO subclassification if possible)
CL Item
Refractory Anaemia (without ring sideroblasts) RA (Refractory Anaemia (without ring sideroblasts) RA)
CL Item
RA with ring sideroblasts (RARS) (RA with ring sideroblasts (RARS))
CL Item
MDS associated with isolated del(5q) (MDS associated with isolated del(5q))
CL Item
Refractory cytopenia with multilineage dysplasia (RCMD) (Refractory cytopenia with multilineage dysplasia (RCMD))
CL Item
Refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS) (Refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS))
CL Item
RA with excess of blasts (RAEB-1) (RA with excess of blasts (RAEB-1))
CL Item
RA with excess of blasts (RAEB-2) (RA with excess of blasts (RAEB-2))
CL Item
Childhood myelodysplastic syndrome (Refractory cytopenia of childhood (RCC)) (Childhood myelodysplastic syndrome (Refractory cytopenia of childhood (RCC)))
CL Item
Unclassified (MDS-U) (Unclassified (MDS-U))
Item
Myelodysplastic Syndrome (FAB)-Subclassification
text
C3463824 (UMLS CUI [1,1])
C2984084 (UMLS CUI [1,2])
C2984084 (UMLS CUI [1,2])
CL Item
RA without ring siderboblasts (RA) (RA without ring siderboblasts (RA))
CL Item
RA with ring siderodblasts (RARS) (RA with ring siderodblasts (RARS))
CL Item
RA with excess of blasts (RAEB) (RA with excess of blasts (RAEB))
CL Item
RAEB in transformation (RAEB-t) (RAEB in transformation (RAEB-t))
CL Item
Unclassified (Unclassified)
Item
Myelodysplastic/ Myeloproliferative Neoplasm Specification
text
C1301355 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,2])
Code List
Myelodysplastic/ Myeloproliferative Neoplasm Specification
CL Item
Chronic Myelomonocytic Leukaemia (CMMoL, CMML) (Chronic Myelomonocytic Leukaemia (CMMoL, CMML))
CL Item
Type I (Type I)
CL Item
Type II (Type II)
CL Item
Juvenile Myelomonocytic Leukaemia (JCMMoL, JMML, JCML, JCMML) (Juvenile Myelomonocytic Leukaemia (JCMMoL, JMML, JCML, JCMML))
CL Item
Atpyical Chronic Myeloid Leukaemia (Atypical CML, t(9;22)negative and BCR/ABL negative) (Atpyical Chronic Myeloid Leukaemia (Atypical CML, t(9;22)negative and BCR/ABL negative))
Item
Secondary Acute Leukaemia Related to prior treatment and not after a previous diagnosis of MDS or MPS).
text
C0280449 (UMLS CUI [1])
Code List
Secondary Acute Leukaemia Related to prior treatment and not after a previous diagnosis of MDS or MPS).
CL Item
Acute Myelogenous Leukaemia (AML) (ProMiSe users: Please use code 1 for main diagnosis) (Acute Myelogenous Leukaemia (AML) (ProMiSe users: Please use code 1 for main diagnosis))
Item
Secondary Origin of Disease If yes, specify cause If yes, specify primary disease
text
C0277555 (UMLS CUI [1])
Code List
Secondary Origin of Disease If yes, specify cause If yes, specify primary disease
CL Item
No (No)
CL Item
Yes (If Secondary Acute Leukaemia, it must always be Yes) (Yes (If Secondary Acute Leukaemia, it must always be Yes))
CL Item
Unknown (Unknown)
Item
Secondary Origin If yes, specify cause
text
C0277555 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
C0015127 (UMLS CUI [1,2])
CL Item
Chemoth./ Radiationth. treated disease (tick all that apply): (Chemoth./ Radiationth. treated disease (tick all that apply):)
CL Item
Alkylating agent/radiation-related (Alkylating agent/radiation-related)
CL Item
Topoisomerase II inhibitor-related (Topoisomerase II inhibitor-related)
CL Item
Radiation (Radiation)
CL Item
Unknown (Unknown)
CL Item
Immune suppression (Immune suppression)
CL Item
After stem cell HSCT (After stem cell HSCT)
CL Item
Other (Other)
CL Item
Unknown (Unknown)
Secondary Origin - cause
Item
Secondary Origin If yes, specify cause If cause other, specify
text
C0277555 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
C0015127 (UMLS CUI [1,2])
Date of diagnosis of Primary Disease
Item
Secondary origin If yes, specify Primary Disease Date of diagnosis of Primary Disease
date
C0277555 (UMLS CUI [1,1])
C0277554 (UMLS CUI [1,2])
C2316983 (UMLS CUI [1,3])
C0277554 (UMLS CUI [1,2])
C2316983 (UMLS CUI [1,3])
Item
Secondary Origin If yes, specify Primary Disease If other, Specify
text
C0277555 (UMLS CUI [1,1])
C0277554 (UMLS CUI [1,2])
C0277554 (UMLS CUI [1,2])
Code List
Secondary Origin If yes, specify Primary Disease If other, Specify
CL Item
AML (AML)
CL Item
ALL (ALL)
CL Item
CML (CML)
CL Item
Other chronic leukaemia (Other chronic leukaemia)
CL Item
NHL (NHL)
CL Item
Hodgkin's disease (Hodgkin's disease)
CL Item
Multiple myeloma (Multiple myeloma)
CL Item
Other plasma cell disorder (Other plasma cell disorder)
CL Item
Solid tumour (Solid tumour)
CL Item
Aplastic anamia (Aplastic anamia)
CL Item
PNH (PNH)
CL Item
Inherited disorder (Inherited disorder)
CL Item
Autoimmune (Autoimmune)
CL Item
Other (Other)
CL Item
unknown (unknown)
Specification of other primary disease
Item
Secondary Origin If yes, specify Primary Disease If other, specify
text
C0277554 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
Cytogenetics Data
Item
Include all analysis before treatment; describe results of most recent complete analysis
text
C0010802 (UMLS CUI [1])
CL Item
Not Done or failed (Not Done or failed)
CL Item
Done: normal (Done: normal)
CL Item
Done: abnormal (Done: abnormal)
CL Item
Unknown (Unknown)
Item
Chromosome analysis If abnormal: are there 3 or more abnormalities (complex kariotype)=
text
C3273253 (UMLS CUI [1])
Code List
Chromosome analysis If abnormal: are there 3 or more abnormalities (complex kariotype)=
CL Item
No (No)
CL Item
Yes (Yes)
CL Item
unknown (unknown)
Cytogenetics data - abnormal metaphases
Item
Chromosome analysis If done: number of metaphases with abnormalities
text
C0025564 (UMLS CUI [1])
Cytogenetics data - examined metaphases
Item
Chromosome analysis If done: number of metaphases examined
text
C0025564 (UMLS CUI [1,1])
C0260877 (UMLS CUI [1,2])
C0260877 (UMLS CUI [1,2])
Item Group
Chromosome Analysis
C0200867 (UMLS CUI-1)
Item
Indicate which abnormalities found:
text
C0200867 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
CL Item
del Y (-Y) (del Y (-Y))
CL Item
del 5q (5q-) (del 5q (5q-))
CL Item
Other abn 5 (Other abn 5)
CL Item
del 20q (20q-) (del 20q (20q-))
CL Item
del 7q (7q-) (del 7q (7q-))
CL Item
Other abn 7 (Other abn 7)
CL Item
Other abnormalities (Other abnormalities)
CL Item
Absent (Absent)
CL Item
Present (Present)
Specification - other
Item
Indicate which abnormalities foud: If other, specify
text
C0200867 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
Item Group
Haematological values (at diagnosis)
C0018941 (UMLS CUI-1)
CL Item
evaluated (evaluated)
CL Item
not evaluated (not evaluated)
Hb
Item
Peripheral Blood Analysis If evaluated: Hb (g/dL)
float
C0518015 (UMLS CUI [1])
Platelets
Item
Peripheral Blood Analysis If evaluated: Platelets (10^9/L)
float
C0005821 (UMLS CUI [1])
White Blood Cells
Item
Peripheral Blood Analysis If evaluated: White Blood Cells (10^9/L)
float
C0023508 (UMLS CUI [1])
blasts
Item
Peripheral Blood Analysis If evaluated: % blasts
float
C0523113 (UMLS CUI [1])
monocytes
Item
Peripheral Blood Analysis If evaluated: % monocytes
float
C0200637 (UMLS CUI [1])
neutrophils
Item
Peripheral Blood Analysis If evaluated: % neutrophils
float
C0027950 (UMLS CUI [1])
CL Item
Evaluated (Evaluated )
CL Item
Not evaluated (Not evaluated)
blasts
Item
Bone marrow analysis: If evaluated: % blasts
float
C1982687 (UMLS CUI [1])
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
Not Evaluated (Not Evaluated)
CL Item
Unknown (Unknown)
Item
Fill only for MDS and CMML; do not fill for treatment related secondary Acute leukaemia, or jMML)
text
C2827405 (UMLS CUI [1])
Code List
Fill only for MDS and CMML; do not fill for treatment related secondary Acute leukaemia, or jMML)
CL Item
Low (0) (Low (0))
CL Item
Intermediate-1 (0.5 - 1.0) (Intermediate-1 (0.5 - 1.0))
CL Item
Intermediate-2 (1.5 - 2) (Intermediate-2 (1.5 - 2))
CL Item
High (> 2.5) (High (> 2.5))
CL Item
Unknown (Unknown)
CL Item
Cytology (Cytology)
CL Item
Histology (Histology)
CL Item
Not available (Not available)
Item
Results (at diagnosis; check one in each column) Cellularity on BM Aspirate/ BM biopsy
text
C1561532 (UMLS CUI [1])
Code List
Results (at diagnosis; check one in each column) Cellularity on BM Aspirate/ BM biopsy
CL Item
Acellular (Acellular)
CL Item
Hypocellular (Hypocellular)
CL Item
Normocellular (Normocellular)
CL Item
Hypercellular (Hypercellular)
CL Item
Focal cellularity (Focal cellularity)
CL Item
Unknown (Unknown)
Item
Results (at diagnosis; check one in each column) Fibrosis on BM biopsy
text
C2355575 (UMLS CUI [1])
CL Item
No (No)
CL Item
Mild (Mild)
CL Item
Moderate (Moderate)
CL Item
Severe (Severe)
CL Item
Not evaluable (Not evaluable)
CL Item
Unknown (Unknown)
First Line Therapy
Item
First Line Therapy given (If No, proceed to "Subclassification & Status of Disease at HSCT" If Yes, specify start date)
boolean
C1708063 (UMLS CUI [1])
Start Date
Item
Start Date of First Line Therapy
date
C0808070 (UMLS CUI [1])
Item
Myelodysplastic Syndrome (WHO)-Subclassification (Please use the WHO subclassification if possible) (If patient had Secondary Acute Leukaemia related to prior treatment, skip this Subclassification section and proceed to Treatment section)
text
C3463824 (UMLS CUI [1,1])
C0043237 (UMLS CUI [1,2])
C0043237 (UMLS CUI [1,2])
Code List
Myelodysplastic Syndrome (WHO)-Subclassification (Please use the WHO subclassification if possible) (If patient had Secondary Acute Leukaemia related to prior treatment, skip this Subclassification section and proceed to Treatment section)
CL Item
Refractory Anaemia (without ring sideroblasts) RA (Refractory Anaemia (without ring sideroblasts) RA)
CL Item
RA with ring sideroblasts (RARS) (RA with ring sideroblasts (RARS))
CL Item
MDS associated with isolated del(5q) (MDS associated with isolated del(5q))
CL Item
Refractory cytopenia with multilineage dysplasia (RCMD) (Refractory cytopenia with multilineage dysplasia (RCMD))
CL Item
Refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS) (Refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS))
CL Item
RA with excess of blasts (RAEB-1) (RA with excess of blasts (RAEB-1))
CL Item
RA with excess of blasts (RAEB-2) (RA with excess of blasts (RAEB-2))
CL Item
Childhood myelodysplastic syndrome (Refractory cytopenia of childhood (RCC)) (Childhood myelodysplastic syndrome (Refractory cytopenia of childhood (RCC)))
CL Item
Unclassified (MDS-U) (Unclassified (MDS-U))
Item
Myelodysplastic Syndrome (FAB)-Subclassification
text
C3463824 (UMLS CUI [1,1])
C2984084 (UMLS CUI [1,2])
C2984084 (UMLS CUI [1,2])
Code List
Myelodysplastic Syndrome (FAB)-Subclassification
CL Item
RA without ring siderboblasts (RA) (RA without ring siderboblasts (RA))
CL Item
RA with ring siderodblasts (RARS) (RA with ring siderodblasts (RARS))
CL Item
RA with excess of blasts (RAEB) (RA with excess of blasts (RAEB))
CL Item
RAEB in transformation (RAEB-t) (RAEB in transformation (RAEB-t))
CL Item
Unclassified (Unclassified)
Item
Myelodysplastic/ Myeloproliferative Neoplasm Specification
text
C1301355 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,2])
Code List
Myelodysplastic/ Myeloproliferative Neoplasm Specification
CL Item
Chronic Myelomonocytic Leukaemia (CMMoL, CMML) (Chronic Myelomonocytic Leukaemia (CMMoL, CMML))
CL Item
Type I (Type I)
CL Item
Type II (Type II)
CL Item
Juvenile Myelomonocytic Leukaemia (JCMMoL, JMML, JCML, JCMML) (Juvenile Myelomonocytic Leukaemia (JCMMoL, JMML, JCML, JCMML))
CL Item
Atpyical Chronic Myeloid Leukaemia (Atypical CML, t(9;22)negative and BCR/ABL negative) (Atpyical Chronic Myeloid Leukaemia (Atypical CML, t(9;22)negative and BCR/ABL negative))
Secondary Acute Leukaemia
Item
If transformed into Secondary Acute Leukaemia, specify date of transformation
date
C0280449 (UMLS CUI [1])
Pharmacotherapy
Item
Chemo/drug/agent
boolean
C0013216 (UMLS CUI [1])
Item
If yes, specify
text
C0013216 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
CL Item
Ara-C (Ara-C)
CL Item
Hydroxyurea (Hydroxyurea)
CL Item
Retinoic acid (Retinoic acid)
CL Item
Hypomethylating agents (Hypomethylating agents)
CL Item
Histondeacetlyase inhibitor (Histondeacetlyase inhibitor)
CL Item
Other (Other)
CL Item
AML like therapy (AML like therapy)
Specification Pharmacotherapy
Item
If other, specify
text
C0013216 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
CL Item
Complete remission (Complete remission)
CL Item
Never in CR (Never in CR)
Date of first complete remission
Item
If complete remission, date of first CR (If subsequent HSCT, indicate the date of the 1st CR after this treatment)
date
C0011008 (UMLS CUI [1,1])
C0677874 (UMLS CUI [1,2])
C0677874 (UMLS CUI [1,2])
Item Group
Subclassification & Status of Disease at HSCT (to be evaluated just before starting conditioning)
C0008902 (UMLS CUI-1)
C0699749 (UMLS CUI-3)
C0699749 (UMLS CUI-3)
Date of HSCT
Item
Date of HSCT
date
C2584899 (UMLS CUI [1])
Splenectomy
Item
jMML only: fill in splenectomy details
boolean
C0037995 (UMLS CUI [1])
Date of Splenectomy
Item
jMML only: fill in splenectomy details if yes, date of splenectomy
date
C2584899 (UMLS CUI [1])
CL Item
No (No)
CL Item
Yes (Yes)
CL Item
Unknown (Unknown)
Item
Transfusion of red blood cells If yes, specify the amount
text
C0086252 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
CL Item
< 20 units (< 20 units)
CL Item
20 - 50 units (20 - 50 units)
CL Item
> 50 units (> 50 units)
CL Item
No (No)
CL Item
Yes (Yes)
CL Item
Unknown (Unknown)
Item
Myelodysplastic Syndrome (WHO)-Subclassification (Please use the WHO subclassification if possible) (if patient had Secondary Acute Leukaemia related to prior treatment, skip this section and proceed to "Disease status at HSCT")
text
C3463824 (UMLS CUI [1,1])
C0043237 (UMLS CUI [1,2])
C0043237 (UMLS CUI [1,2])
Code List
Myelodysplastic Syndrome (WHO)-Subclassification (Please use the WHO subclassification if possible) (if patient had Secondary Acute Leukaemia related to prior treatment, skip this section and proceed to "Disease status at HSCT")
CL Item
Refractory Anaemia (without ring sideroblasts) RA (Refractory Anaemia (without ring sideroblasts) RA)
CL Item
RA with ring sideroblasts (RARS) (RA with ring sideroblasts (RARS))
CL Item
MDS associated with isolated del(5q) (MDS associated with isolated del(5q))
CL Item
Refractory cytopenia with multilineage dysplasia (RCMD) (Refractory cytopenia with multilineage dysplasia (RCMD))
CL Item
Refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS) (Refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS))
CL Item
RA with excess of blasts (RAEB-1) (RA with excess of blasts (RAEB-1))
CL Item
RA with excess of blasts (RAEB-2) (RA with excess of blasts (RAEB-2))
CL Item
Childhood myelodysplastic syndrome (Refractory cytopenia of childhood (RCC)) (Childhood myelodysplastic syndrome (Refractory cytopenia of childhood (RCC)))
CL Item
Unclassified (MDS-U) (Unclassified (MDS-U))
Item
Myelodysplastic Syndrome (FAB)-Subclassification
text
C3463824 (UMLS CUI [1,1])
C2984084 (UMLS CUI [1,2])
C2984084 (UMLS CUI [1,2])
CL Item
RA without ring siderboblasts (RA) (RA without ring siderboblasts (RA))
CL Item
RA with ring siderodblasts (RARS) (RA with ring siderodblasts (RARS))
CL Item
RA with excess of blasts (RAEB) (RA with excess of blasts (RAEB))
CL Item
RAEB in transformation (RAEB-t) (RAEB in transformation (RAEB-t))
CL Item
Unclassified (Unclassified)
Item
Myelodysplastic/ Myeloproliferative Neoplasm Specification
text
C1301355 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,2])
Code List
Myelodysplastic/ Myeloproliferative Neoplasm Specification
CL Item
Chronic Myelomonocytic Leukaemia (CMMoL, CMML) (Chronic Myelomonocytic Leukaemia (CMMoL, CMML))
CL Item
Type I (Type I)
CL Item
Type II (Type II)
CL Item
Juvenile Myelomonocytic Leukaemia (JCMMoL, JMML, JCML, JCMML) (Juvenile Myelomonocytic Leukaemia (JCMMoL, JMML, JCML, JCMML))
CL Item
Atpyical Chronic Myeloid Leukaemia (Atypical CML, t(9;22)negative and BCR/ABL negative) (Atpyical Chronic Myeloid Leukaemia (Atypical CML, t(9;22)negative and BCR/ABL negative))
Secondary Acute Leukaemia
Item
If transformed into Secondary Acute Leukaemia, specify date of transformation
date
C0280449 (UMLS CUI [1])
Item
Treated with intention to achieve remission: (For all diagnosis except jMML (see below for jMML))
text
C0699749 (UMLS CUI [1])
Code List
Treated with intention to achieve remission: (For all diagnosis except jMML (see below for jMML))
CL Item
Primary refractory phase (no change) (Primary refractory phase (no change))
CL Item
Complete remission (CR) (Complete remission (CR))
CL Item
Improvement but no CR (Improvement but no CR)
CL Item
Relapse (after CR) (Relapse (after CR))
CL Item
Progression/ worse (Progression/ worse)
CL Item
Untreated (Supportive care or treatment without intetion to achieve remission) (Untreated (Supportive care or treatment without intetion to achieve remission))
Item
If CR or relapse, specify number:
text
C0677874 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C0277556 (UMLS CUI [2,1])
C0237753 (UMLS CUI [2,2])
C0237753 (UMLS CUI [1,2])
C0277556 (UMLS CUI [2,1])
C0237753 (UMLS CUI [2,2])
CL Item
1st (1st)
CL Item
2nd (2nd)
CL Item
3rd or higher (3rd or higher)
Item
For jMML only:
text
C0699749 (UMLS CUI [1,1])
C0349639 (UMLS CUI [1,2])
C0349639 (UMLS CUI [1,2])
CL Item
Complete remission (Complete remission)
CL Item
Partial remission (Partial remission)
CL Item
Minor response (Minor response)
CL Item
Stable disease (Stable disease)
CL Item
Progressive disease (Progressive disease)
Item Group
Cytogenetics Data (Within 2 months of the preparative -conditioning- regimen)
CL Item
Not Done or failed (Not Done or failed)
CL Item
Done: normal (Done: normal)
CL Item
Done: abnormal (Done: abnormal)
CL Item
Unknown (Unknown)
Item
if abnormal: are there 3 or more abnormalities (complex kariotype)
text
C3273253 (UMLS CUI [1])
CL Item
No (No)
CL Item
Yes (Yes)
CL Item
Unknown (Unknown)
Item
Indicate which abnormalties found:
text
C0200867 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
CL Item
del Y (-Y) (del Y (-Y))
CL Item
del 5q (5q-) (del 5q (5q-))
CL Item
Other abn 5 (Other abn 5)
CL Item
del 20q (20q-) (del 20q (20q-))
CL Item
del 7q (7q-) (del 7q (7q-))
CL Item
Other abn 7 (Other abn 7)
CL Item
Other abnormalities (Other abnormalities)
CL Item
absent (absent)
CL Item
present (present)
Specification - other
Item
If other, specify:
text
C0200867 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
Item Group
Haematological values at HSCT (to be evaluated just before starting the preparative -conditioning- regimen)
CL Item
evaluated (evaluated)
CL Item
not evaluated (not evaluated)
Hb
Item
Peripheral Blood Analysis If evaluated: Hb (g/dL)
float
C0518015 (UMLS CUI [1])
Platelets
Item
Peripheral Blood Analysis If evaluated: Platelets (10^9/L)
float
C0005821 (UMLS CUI [1])
White Blood Cells
Item
Peripheral Blood Analysis If evaluated: White Blood Cells (10^9/L)
float
C0005821 (UMLS CUI [1])
blasts
Item
Peripheral blood analysis If evaluated: % blasts
float
C0523113 (UMLS CUI [1])
monocytes
Item
Peripheral blood analysis: If evaluated: % monocytes
float
C0200637 (UMLS CUI [1])
neutrophils
Item
Peripheral blood analysis: If evaluated: % neutrophils
float
C0027950 (UMLS CUI [1])
CL Item
Evaluated (Evaluated)
CL Item
Not evaluated (Not evaluated)
blasts
Item
Bone marrow analysis: If evaluated: % blasts
float
C1982687 (UMLS CUI [1])
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
Not Evaluated (Not Evaluated)
CL Item
Unknown (Unknown)
CL Item
Low (0) (Low (0))
CL Item
Intermediate-1 (0.5 - 1.0) (Intermediate-1 (0.5 - 1.0))
CL Item
Intermediate-2 (1.5 - 2) (Intermediate-2 (1.5 - 2))
CL Item
High (> 2.5) (High (> 2.5))
CL Item
Unknown (Unknown)
Item
Within 2 months of the preparative -conditoning- regimen:
text
C0005957 (UMLS CUI [1])
CL Item
Cytology (Cytology)
CL Item
Histology (Histology)
CL Item
Not available (Not available)
Item
Results (at diagnosis; check one in each column) Cellularity on BM Aspirate/ BM biopsy
text
C1561532 (UMLS CUI [1])
Code List
Results (at diagnosis; check one in each column) Cellularity on BM Aspirate/ BM biopsy
CL Item
Acellular (Acellular)
CL Item
Hypocellular (Hypocellular)
CL Item
Normocellular (Normocellular)
CL Item
Hypercellular (Hypercellular)
CL Item
Focal cellularity (Focal cellularity)
CL Item
Unknown (Unknown)
Item
Results (at diagnosis; check one in each column) Fibrosis on BM biopsy
text
C2355575 (UMLS CUI [1])
CL Item
No (No)
CL Item
Mild (Mild)
CL Item
Moderate (Moderate)
CL Item
Severe (Severe)
CL Item
Not evaluable (Not evaluable)
CL Item
Unknown (Unknown)
CL Item
No (No)
CL Item
Yes (Yes)
CL Item
Unknown (Unknown)
Item
If yes, planned or not planned
text
C1706712 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,2])
CL Item
Planned (planned before HSCT took place) (Planned (planned before HSCT took place))
CL Item
Not planned (for relapse/ progression or persistent disease) (Not planned (for relapse/ progression or persistent disease))
Start date of additional treatment Post-HSCT
Item
If yes, specify start date:
date
C1706712 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
Item
If yes: Chemo/ drug/agent therapy (including MoAB, etc.)
text
C1706712 (UMLS CUI [1,1])
C0013216 (UMLS CUI [1,2])
C0013216 (UMLS CUI [1,2])
CL Item
No (No )
CL Item
Yes (Yes)
CL Item
Unknown (Unknown)
Pharmacotherapy Specification
Item
If additional chemo/drug/agent treatment, specify:
text
C0013216 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
CL Item
No (No)
CL Item
Yes (Yes)
CL Item
Unknown (Unknown)
Other Additional Treatment Post-HSCT - Specification
Item
If other treatment, specify:
text
C1706712 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
Item
Best Disease Response at 100 days post-HSCT
text
C1704632 (UMLS CUI [1])
CL Item
CR (maintained or achieved) (CR (maintained or achieved))
CL Item
Relapse/ Progression (Relapse/ Progression)
CL Item
Unknown (Unknown)
CL Item
Not evaluable (Not evaluable)
CL Item
AUTOgraft, proceed to Autograft form (AUTOgraft, proceed to Autograft form)
CL Item
ALLOgraft or Synergenic graft, proceed to Allograft form (ALLOgraft or Synergenic graft, proceed to Allograft form)
CL Item
Other, contact the EBMT Central Registry Office for instructions (Other, contact the EBMT Central Registry Office for instructions)
Other Type of HSCT
Item
If other, specify, and contact the EBMT Central Registry Office for instructions
text
C0472699 (UMLS CUI [1])